KERALA AYURVEDA
Back to Income Statement
|
KERALA AYURVEDA Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹-1.56 Cr | ₹-0.53 Cr | ₹2.36 Cr | ₹-4.84 Cr | ₹3.90 Cr |
What is the latest Consolidated Net Profit of KERALA AYURVEDA ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹-1.56 Cr |
Mar2023 | ₹-0.53 Cr |
Mar2022 | ₹2.36 Cr |
Mar2021 | ₹-4.84 Cr |
Mar2020 | ₹3.90 Cr |
How is Consolidated Net Profit of KERALA AYURVEDA Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹-1.56 Cr | Negative | |
Mar2023 | ₹-0.53 Cr | Negative | |
Mar2022 | ₹2.36 Cr | Positive | |
Mar2021 | ₹-4.84 Cr | Negative | |
Mar2020 | ₹3.90 Cr | - |
Compare Consolidated Net Profit of peers of KERALA AYURVEDA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KERALA AYURVEDA | ₹443.5 Cr | 4.8% | -0.4% | 27.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,648.0 Cr | -4.9% | 2.1% | 15.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,310.0 Cr | -2.2% | 9.3% | 50.5% | Stock Analytics | |
CIPLA | ₹119,410.0 Cr | -4.2% | 4.5% | 4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,189.0 Cr | -4.4% | -4.5% | 17.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,496.4 Cr | -1.4% | 4.2% | -8.8% | Stock Analytics |
KERALA AYURVEDA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KERALA AYURVEDA | 4.8% |
-0.4% |
27.5% |
SENSEX | -1.3% |
4.1% |
7.6% |
You may also like the below Video Courses